PBPK modeling of recombinant factor IX Fc fusion protein (rFIXFc) and rFIX to characterize the binding to type 4 collagen in the extravascular space.

MLA

Cloesmeijer, Michael E., et al. “PBPK Modeling of Recombinant Factor IX Fc Fusion Protein (RFIXFc) and RFIX to Characterize the Binding to Type 4 Collagen in the Extravascular Space.” CPT: Pharmacometrics & Systems Pharmacology, vol. 13, no. 10, Oct. 2024, pp. 1630–40. EBSCOhost, https://doi.org/10.1002/psp4.13159.

APA

Cloesmeijer, M. E., Sjögren, E., Koopman, S. F., Lenting, P. J., Cnossen, M. H., & Mathôt, R. A. A. (2024). PBPK modeling of recombinant factor IX Fc fusion protein (rFIXFc) and rFIX to characterize the binding to type 4 collagen in the extravascular space. CPT: Pharmacometrics & Systems Pharmacology, 13(10), 1630–1640. https://doi.org/10.1002/psp4.13159

Chicago

Cloesmeijer, Michael E, Erik Sjögren, Sjoerd F Koopman, Peter J Lenting, Marjon H Cnossen, and Ron A A Mathôt. 2024. “PBPK Modeling of Recombinant Factor IX Fc Fusion Protein (RFIXFc) and RFIX to Characterize the Binding to Type 4 Collagen in the Extravascular Space.” CPT: Pharmacometrics & Systems Pharmacology 13 (10): 1630–40. doi:10.1002/psp4.13159.